Smarter prostate biopsy using imaging and metabolic data
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new biopsy system that uses MRI images and metabolic information to guide doctors to the most suspicious areas of the prostate during the biopsy. This could make the biopsy more accurate and help diagnose prostate cancer better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 55 years old
- Your doctor has recommended a prostate biopsy
- You have had a blood test for PSA (prostate-specific antigen) and an MRI of the prostate within the last month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
This study tests a new computer program that reads MRI scans to help doctors decide if a prostate biopsy is truly needed. It aims to reduce unnecessary biopsies for men with suspicious test results.
This study tests a new computer program that reads prostate MRI images to help doctors diagnose prostate cancer more accurately. It may help you by providing a clearer picture of your condition without extra tests.
This study looks at using advanced MRI techniques to better spot prostate cancer, aiming to reduce unnecessary biopsies. It has two parts: one calibrates MRI scanners across hospitals, the other tests the new method in patients with suspicious MRI findings.
This study uses advanced MRI scans to better identify prostate cancer lesions before biopsy or surgery. It may help men who already have suspicious MRI findings and are scheduled for a prostate biopsy or removal.
This trial tests if using MRI and a blood test called PHI can help decide who needs a prostate biopsy. It aims to avoid unnecessary biopsies while still catching cancer early.
Hear when a new Prostate Cancer (Adenocarcinoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.